Argent Trust Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
2,050
-96
| -4% | -$50.4K | 0.04% | 309 |
|
|
2025
Q1 | $1.36M | Sell |
2,146
-46
| -2% | -$29.2K | 0.06% | 270 |
|
|
2024
Q4 | $1.56M | Sell |
2,192
-197
| -8% | -$140K | 0.06% | 255 |
|
|
2024
Q3 | $2.51M | Buy |
2,389
+19
| +0.8% | +$20K | 0.1% | 183 |
|
|
2024
Q2 | $2.49M | Buy |
2,370
+31
| +1% | +$32.6K | 0.11% | 171 |
|
|
2024
Q1 | $2.25M | Buy |
2,339
+176
| +8% | +$169K | 0.1% | 190 |
|
|
2023
Q4 | $1.9M | Buy |
2,163
+96
| +5% | +$84.3K | 0.09% | 196 |
|
|
2023
Q3 | $1.7M | Buy |
2,067
+91
| +5% | +$74.9K | 0.09% | 188 |
|
|
2023
Q2 | $1.42M | Buy |
1,976
+457
| +30% | +$328K | 0.08% | 219 |
|
|
2023
Q1 | $1.25M | Sell |
1,519
-11
| -0.7% | -$9.04K | 0.08% | 210 |
|
|
2022
Q4 | $1.1M | Sell |
1,530
-39
| -2% | -$28.1K | 0.07% | 226 |
|
|
2022
Q3 | $1.08M | Buy |
1,569
+35
| +2% | +$24.1K | 0.08% | 217 |
|
|
2022
Q2 | $907K | Buy |
1,534
+21
| +1% | +$12.4K | 0.06% | 248 |
|
|
2022
Q1 | $1.06M | Sell |
1,513
-14
| -0.9% | -$9.78K | 0.06% | 241 |
|
|
2021
Q4 | $964K | Buy |
1,527
+1,173
| +331% | +$741K | 0.06% | 263 |
|
|
2021
Q3 | $214K | Buy |
+354
| New | +$214K | 0.01% | 502 |
|